(BWXT) BWX Technologies - Ratings and Ratios
Nuclear Components, Reactors, Nuclear Fuel, Valves, Pressure Vessels
BWXT EPS (Earnings per Share)
BWXT Revenue
Description: BWXT BWX Technologies
BWX Technologies, Inc. is a leading manufacturer and supplier of nuclear components and services, operating through two main segments: Government Operations and Commercial Operations. The companys diverse product portfolio includes precision naval nuclear components, reactors, and nuclear fuel, as well as commercial nuclear steam generators, nuclear fuel, and fuel handling systems.
From a strategic perspective, BWXTs business is driven by the growing demand for nuclear energy and the need for advanced nuclear technologies. The companys expertise in nuclear component manufacturing and its strong research and development capabilities position it for long-term growth. Key performance indicators (KPIs) to watch include revenue growth, order backlog, and the companys ability to execute on its contract pipeline.
Analyzing BWXTs financials, we can see that the company has a strong market capitalization of $12.78B USD and a return on equity (ROE) of 27.28%, indicating a high level of profitability. The companys forward price-to-earnings (P/E) ratio of 43.10 suggests that investors have high expectations for future earnings growth. Other key metrics to monitor include the companys dividend yield, free cash flow margin, and debt-to-equity ratio.
From a competitive standpoint, BWXT operates in a niche market with high barriers to entry, providing a degree of protection against new entrants. The companys strong brand reputation, extensive experience, and proprietary technologies are significant competitive advantages. As the nuclear industry continues to evolve, BWXTs ability to adapt and innovate will be critical to its long-term success.
BWXT Stock Overview
Market Cap in USD | 15,967m |
Sub-Industry | Aerospace & Defense |
IPO / Inception | 2010-08-02 |
BWXT Stock Ratings
Growth Rating | 75.9 |
Fundamental | 70.7% |
Dividend Rating | 54.9 |
Rel. Strength | 23.7 |
Analysts | 4.27 of 5 |
Fair Price Momentum | 192.76 USD |
Fair Price DCF | 95.57 USD |
BWXT Dividends
Dividend Yield 12m | 0.69% |
Yield on Cost 5y | 1.81% |
Annual Growth 5y | 4.78% |
Payout Consistency | 99.1% |
Payout Ratio | 27.6% |
BWXT Growth Ratios
Growth Correlation 3m | 90.2% |
Growth Correlation 12m | 45.4% |
Growth Correlation 5y | 83.3% |
CAGR 5y | 25.89% |
CAGR/Max DD 5y | 0.71 |
Sharpe Ratio 12m | 1.25 |
Alpha | 58.50 |
Beta | 1.149 |
Volatility | 27.16% |
Current Volume | 902.2k |
Average Volume 20d | 1026.2k |
Stop Loss | 168 (-3.2%) |
Signal | 0.16 |
Piotroski VR‑10 (Strict, 0-10) 6.5
Net Income (294.4m TTM) > 0 and > 6% of Revenue (6% = 171.9m TTM) |
FCFTA 0.10 (>2.0%) and ΔFCFTA 0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 14.20% (prev 19.27%; Δ -5.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.14 (>3.0%) and CFO 519.2m > Net Income 294.4m (YES >=105%, WARN >=100%) |
Net Debt (1.50b) to EBITDA (465.0m) ratio: 3.22 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.69 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (91.7m) change vs 12m ago -0.11% (target <= -2.0% for YES) |
Gross Margin 24.26% (prev 25.35%; Δ -1.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 87.60% (prev 91.56%; Δ -3.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 16.62 (EBITDA TTM 465.0m / Interest Expense TTM 22.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.61
(A) 0.11 = (Total Current Assets 996.9m - Total Current Liabilities 590.2m) / Total Assets 3.70b |
(B) 0.65 = Retained Earnings (Balance) 2.39b / Total Assets 3.70b |
(C) 0.12 = EBIT TTM 381.2m / Avg Total Assets 3.27b |
(D) 0.94 = Book Value of Equity 2.37b / Total Liabilities 2.52b |
Total Rating: 4.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 70.73
1. Piotroski 6.50pt = 1.50 |
2. FCF Yield 2.06% = 1.03 |
3. FCF Margin 12.58% = 3.14 |
4. Debt/Equity 1.29 = 1.72 |
5. Debt/Ebitda 3.30 = -2.13 |
6. ROIC - WACC 3.67% = 4.59 |
7. RoE 26.62% = 2.22 |
8. Rev. Trend 82.59% = 4.13 |
9. Rev. CAGR 13.42% = 1.68 |
10. EPS Trend 80.74% = 2.02 |
11. EPS CAGR 8.34% = 0.83 |
What is the price of BWXT shares?
Over the past week, the price has changed by -3.18%, over one month by +26.23%, over three months by +59.79% and over the past year by +78.32%.
Is BWX Technologies a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BWXT is around 192.76 USD . This means that BWXT is currently undervalued and has a potential upside of +11.1% (Margin of Safety).
Is BWXT a buy, sell or hold?
- Strong Buy: 6
- Buy: 3
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the BWXT price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 181.5 | 4.6% |
Analysts Target Price | 134.6 | -22.4% |
ValueRay Target Price | 216.7 | 24.9% |
Last update: 2025-08-16 05:01
BWXT Fundamental Data Overview
CCE Cash And Equivalents = 37.0m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 54.4237
P/E Forward = 52.9101
P/S = 5.5742
P/B = 13.4841
P/EG = 2.31
Beta = 0.72
Revenue TTM = 2.86b USD
EBIT TTM = 381.2m USD
EBITDA TTM = 465.0m USD
Long Term Debt = 1.52b USD (from longTermDebt, last quarter)
Short Term Debt = 12.5m USD (from shortTermDebt, last quarter)
Debt = 1.53b USD (Calculated: Short Term 12.5m + Long Term 1.52b)
Net Debt = 1.50b USD (from netDebt column, last quarter)
Enterprise Value = 17.46b USD (15.97b + Debt 1.53b - CCE 37.0m)
Interest Coverage Ratio = 16.62 (Ebit TTM 381.2m / Interest Expense TTM 22.9m)
FCF Yield = 2.06% (FCF TTM 360.3m / Enterprise Value 17.46b)
FCF Margin = 12.58% (FCF TTM 360.3m / Revenue TTM 2.86b)
Net Margin = 10.28% (Net Income TTM 294.4m / Revenue TTM 2.86b)
Gross Margin = 24.26% ((Revenue TTM 2.86b - Cost of Revenue TTM 2.17b) / Revenue TTM)
Tobins Q-Ratio = 7.36 (Enterprise Value 17.46b / Book Value Of Equity 2.37b)
Interest Expense / Debt = 0.77% (Interest Expense 11.7m / Debt 1.53b)
Taxrate = 19.05% (from yearly Income Tax Expense: 66.4m / 348.7m)
NOPAT = 308.6m (EBIT 381.2m * (1 - 19.05%))
Current Ratio = 1.69 (Total Current Assets 996.9m / Total Current Liabilities 590.2m)
Debt / Equity = 1.29 (Debt 1.53b / last Quarter total Stockholder Equity 1.18b)
Debt / EBITDA = 3.30 (Net Debt 1.50b / EBITDA 465.0m)
Debt / FCF = 4.25 (Debt 1.53b / FCF TTM 360.3m)
Total Stockholder Equity = 1.11b (last 4 quarters mean)
RoA = 7.96% (Net Income 294.4m, Total Assets 3.70b )
RoE = 26.62% (Net Income TTM 294.4m / Total Stockholder Equity 1.11b)
RoCE = 14.52% (Ebit 381.2m / (Equity 1.11b + L.T.Debt 1.52b))
RoIC = 13.08% (NOPAT 308.6m / Invested Capital 2.36b)
WACC = 9.41% (E(15.97b)/V(17.50b) * Re(10.25%)) + (D(1.53b)/V(17.50b) * Rd(0.77%) * (1-Tc(0.19)))
Shares Correlation 5-Years: -70.0 | Cagr: -0.17%
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 75.22% ; FCFE base≈317.2m ; Y1≈405.8m ; Y5≈753.3m
Fair Price DCF = 95.57 (DCF Value 8.73b / Shares Outstanding 91.4m; 5y FCF grow 30.0% → 3.0% )
Revenue Correlation: 82.59 | Revenue CAGR: 13.42%
Revenue Growth Correlation: -18.47%
EPS Correlation: 80.74 | EPS CAGR: 8.34%
EPS Growth Correlation: -28.78%
Additional Sources for BWXT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle